2026 Khalid Shah: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	62	10784	9951	4684	4203	171	13980

Khalid Shah publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Khalid Shah sits on this spectrum.

47 publications 1,028+

This scientist: 171 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Khalid Shah D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Khalid Shah sits on this spectrum.

40 D-Index 167+

This scientist: 62 D-Index — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Khalid Shah is affiliated with Brigham and Women's Hospital in the United States and has a research portfolio that spans multiple disciplines within medicine, biochemistry, genetics, and molecular biology. Their work has contributed to advancing knowledge in fields such as molecular biology, immunology, oncology, genetics, and pulmonary and respiratory medicine.

The scientist's research frequently focuses on topics including:

CAR-T cell therapy research
Virus-based gene therapy research
Immunotherapy and immune responses
Glioma diagnosis and treatment
Brain metastases and treatment
Cancer research and treatments
Mesenchymal stem cell research

Khalid Shah has published in a variety of scientific venues, often contributing to journals such as:

Cytotherapy
Cancer Research
bioRxiv (Cold Spring Harbor Laboratory)
Nature Communications
Clinical Cancer Research

Examples of recent publications include:

"Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential," 2020, Trends in Pharmacological Sciences
"Shattering barriers toward clinically meaningful MSC therapies," 2020, Science Advances
"Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS," 2022, EBioMedicine
"Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics," 2020, Frontiers in Oncology
"Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types," 2020, Nature Communications

The scientist collaborates regularly with several coauthors, including:

Rachele Ciccocioppo
Jaap Jan Boelens
Ekaterina Doubrovina
Miguel Forte
Jacques Galipeau

Best Publications

Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential.

Na Song;Na Song;Na Song;Martijn Scholtemeijer;Martijn Scholtemeijer;Khalid Shah;Khalid Shah

637
Citations
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

Rachael A Evans;Hamish McAuley;Ewen M Harrison;Aarti Shikotra

624
Citations
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

Laura S. Sasportas;Randa Kasmieh;Hiroaki Wakimoto;Shawn Hingtgen

564
Citations
MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.

Maarten F. Corsten;Rafael Miranda;Randa Kasmieh;Anna M. Krichevsky

534
Citations
Shattering barriers toward clinically meaningful MSC therapies.

Oren Levy;Rui Kuai;Rui Kuai;Erika M. J. Siren;Deepak Bhere

459
Citations
Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors

Hiroaki Wakimoto;Santosh Kesari;Christopher J. Farrell;William T. Curry

407
Citations
Mesenchymal stem cells engineered for cancer therapy.

Khalid Shah

374
Citations
TRAIL on trial: preclinical advances in cancer therapy.

Daniel W. Stuckey;Khalid Shah

320
Citations
In vivo tracking of neural progenitor cell migration to glioblastomas.

Yi Tang;Khalid Shah;Shanta M. Messerli;Evan Snyder

279
Citations
Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas

Timo M. Kauer;Jose Luiz Figueiredo;Shawn Hingtgen;Khalid Shah

252
Citations
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

James P. Sullivan;Brian V. Nahed;Marissa W. Madden;Samantha M. Oliveira

249
Citations
Molecular imaging of gene therapy for cancer.

K. Shah;Andreas Jacobs;X. O. Breakefield;R. Weissleder

248
Citations
The Arabidopsis kinase-associated protein phosphatase controls internalization of the somatic embryogenesis receptor kinase 1

Khalid Shah;Eugenia Russinova;Theodorus W.J. Gadella;Joost Willemse

238
Citations
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics.

Emily Y. Yang;Khalid Shah;Khalid Shah

237
Citations
Stem cell-based therapies for cancer treatment: separating hope from hype

Daniel W. Stuckey;Khalid Shah

232
Citations
Molecular optical imaging: applications leading to the development of present day therapeutics.

Khalid Shah;Ralph Weissleder

228
Citations
Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.

Khalid Shah;Emilie Bureau;Dong-Eog Kim;Katherine Yang

226
Citations
In Vivo Imaging of β-Galactosidase Activity Using Far Red Fluorescent Switch

Ching Hsuan Tung;Qing Zeng;Khalid Shah;Dong Eog Kim

215
Citations
Imaging of Stem Cell Recruitment to Ischemic Infarcts in a Murine Model

Dong Eog Kim;Dawid Schellingerhout;Ken Ishii;Khalid Shah

198
Citations
Molecular Mechanism of Chemoresistance by Astrocyte Elevated Gene-1

Byoung Kwon Yoo;Dong Chen;Zhao-zhong Su;Rachel Gredler

149
Citations